Home›People›Karl Thor
Karl Thor

Karl Thor

Chief Scientific Officer and director at Dignify Therapeutics.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About Karl Thor

Karl Thor is a chief scientific officer and director at Dignify Therapeutics.

Karl Thor first appears on SEC filings in 2014.

Experience

This experience comes from Karl Thor's profile and from SEC filings. For roles taken from filings, the years are when the filings name Karl Thor in the role, so the role may have started earlier or lasted longer.

Dignify Therapeutics, LLC Current
Chief Scientific Officer and director
2013 – Present · Research Triangle Park, NC
Develops bowel and bladder drugs for older adults and people with neurological conditions.
Imurj, LLC
Managing Partner
2013 – 2020
Urogenix, Inc.
V.P. Research
2006 – 2012
Dynogen Pharmaceuticals, Inc.
Sr. VP Research
2002 – 2006
PPD GenuPro
V.P.
1998 – 2002
Eli Lilly
Scientist
1990 – 1998
Lilly Research Laboratories
Research Scientist
1990 – 1998

Key Colleagues at Startups

The people Karl Thor works with at each company, as listed on that company's latest Form D.

Dignify Therapeutics, LLC · Form D, Sep 25, 2026
HP
NK
Neil Kurtz
Director
Anthony DiTonno
Anthony DiTonno
CEO and director
EG
Eric Green
Director
Edward Burgard
Edward Burgard
President and director

Sources

  1. SECDignify Therapeutics, LLC Form D, filed Sep 25, 2026